Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

18 March 2021 : Clinical Research  

Atosiban Combined with Ritodrine for Late Threatened Abortion or Threatened Premature Labor Patients with No Response to Ritodrine: A Clinical Trial

Shuai Fu1ABC, Haitian Xie1DEF, Yilei Zhong12BCD, Qi Xu1D, Liqiong Zhu1B, Hanjie Mo1B, Jianping Zhang1AG, Yinglin Liu1CF, Hui Chen1AG, Yonghong Zhong2AD*, Jianping Tan1AD

DOI: 10.12659/MSM.929743

Med Sci Monit 2021; 27:e929743

Table 5 Adverse drug reactions. Categorical data are shown as a frequency (percentage) and continuous data are shown as mean±SD. The t test was used for analyzing quantitative data, and the χ2 test was used for analyzing categorical data. P<0.05 was considered statistically significant.

ItemsControl group (n=22)Research group (n=30)P
Mean heart rate (times/min)98.77±9.0697.46±15.840.703
Palpitations (%)68.20 (15/22)13.30 (4/30)<0.001*
Chest pain (%)0.00 (0/22)6.67 (2/30)0.520
*

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750